MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)—implementation of a national guideline in Canada

MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)—implementation of a national guideline in Canada

Abstract Background Evidence supports magnesium sulphate (MgSO4) for women at risk of imminent birth at < 32–34 weeks to reduce the likelihood of cerebral palsy in the child. MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP) was a multifaceted knowledge translation (...

Full description

Bibliographic Details
Main Authors: Dane A. De Silva, Anne R. Synnes, Peter von Dadelszen, Tang Lee, Jeffrey N. Bone, MAG-CP, CPN and CNN collaborative groups, Laura A. Magee
Format: Article
Language:English
Published: BMC 2018-01-01
Series:Implementation Science
Subjects:
Preterm birth
Fetal neuroprotection
Magnesium sulphate
Cerebral palsy
Knowledge translation
Implementation
Online Access:http://link.springer.com/article/10.1186/s13012-017-0702-9

Internet

http://link.springer.com/article/10.1186/s13012-017-0702-9

Similar Items